Journal: PLoS ONE
Article Title: The Transcriptional Cofactor Nab2 Is Induced by TGF-β and Suppresses Fibroblast Activation: Physiological Roles and Impaired Expression in Scleroderma
doi: 10.1371/journal.pone.0007620
Figure Lengend Snippet: Lesional skin biopsies were obtained from patients with scleroderma (n = 6) and healthy controls (n = 3), and processed for immunohistochemistry as described under . A. Nab2 expression. Skin biopsies from healthy controls (a, b, e) and scleroderma patients (c, d, f, g, h–l). Original magnification ×100(a, h), ×400 (b, d, i), ×630 (c, e, f, j, k, l). Note uniformly intense Nab2 nuclear immunoreactivity in epithelial cells in scleroderma skin biopsies (h, i, l), as well as in perifollicular and periglandular (c, d, g) epithelial cells and vascular endothelial cells (f, j), compared to weak and variable Nab2 expression seen in occasional dermal fibroblasts (k, l). Representative photomicrographs; similar immunostaining pattern was observed in all six scleroderma skin biopsies. B. Phospho-Smad2 (a–d) or Egr-1 (e–h) expression. Nuclei are counterstained with hematoxylin (blue). Note strong immunostaining in dermal fibroblasts in scleroderma (d, h) skin biopsies compared to healthy controls (b, f).
Article Snippet: Following incubation of the slides using primary antibodies against anti-mouse Nab2 monoclonal antibodies (Santa Cruz, 1∶50 dilution), anti-rabbit phospho-Smad2 (Cell Signaling Technology, 1∶100 dilution), and anti-rabbit Egr-1 (Santa Cruz, 1∶100 dilution), appropriate goat anti-mouse IgG or donkey anti goat IgG (Dako) were applied as secondary antibodies.
Techniques: Immunohistochemistry, Expressing, Immunostaining